Literature DB >> 31982438

Analyzing Outcomes of Nuss and Ravitch Repair for Primary and Recurrent Pectus Excavatum in Adults.

Gregory R Toci1, Trevor A Davis2, Benjamin F Bigelow1, Stephen C Yang3.   

Abstract

BACKGROUND: Limited data exist for pectus excavatum repair in adults. We reviewed outcomes in adult patients undergoing Ravitch or Nuss pectus excavatum repairs to determine whether there was a statistical difference in postoperative complications and recurrence between primary and redo operations.
METHODS: Patients undergoing pectus excavatum repair between 2001 and 2018 were excluded if they were receiving a concurrent unrelated operation, aged younger than 18 years, or had less than 1 year of follow-up (for recurrence analysis). Postoperative complications were recorded based on procedure type (Ravitch/Nuss) and iteration of repair (primary/redo). Continuous patient data were compared using Student t tests for variables such as age, length of stay, estimated blood loss, body mass index, and number of bars inserted. Fisher exact or χ2 tests were performed for postoperative complications and recurrence rates between groups.
RESULTS: Of 290 patients, there were no significant differences in postoperative complications or recurrence rates between all Nuss repairs (n = 237; P = .59) and all Ravitch repairs (n = 53; P = .48), redo Nuss repairs (n = 53; P = .26) and Ravitch repairs (n=26; P = .99), and primary (P = .26) and redo Nuss (P = .10) repairs or primary (P = .99) and redo Ravitch (P = .99) repairs. There were significant differences in age, length of stay, follow-up, bars inserted, and estimated blood loss between all Nuss and Ravitch repairs (P < .05).
CONCLUSIONS: Postoperative complication and recurrence rates were not statistically different between Nuss and Ravitch procedures of all types, suggesting either procedure may have utility in recurrent pectus excavatum. Further research may look to expand sample size and a prospective study investigating long-term outcomes.
Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 31982438     DOI: 10.1016/j.athoracsur.2019.12.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  "When to Nuss? patient age as a risk factor for complications of minimally invasive repair of pectus excavatum: a systematic review and meta-analysis".

Authors:  Arielle C Coughlin; Sofia Ahsanuddin; Dani Inglesby; Conner Fox; Hope Xu; Ilana Margulies; Farah Sayegh; Celine Soudant; Henry S Sacks; Andrew Kaufman; Peter J Taub
Journal:  Pediatr Surg Int       Date:  2022-01-10       Impact factor: 1.827

2.  Effect of minimally invasive repair of pectus excavatum on postoperative chest flatness, cardiopulmonary function, and bone metabolism indexes in children at different ages.

Authors:  Qianli Liu; Wenlin Wang; Chun Hong; Wei Liu; Yang Liu; Ziyin Shang; Jing Tang; Cuifen Liu; Yingxing Liu
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

3.  Factors influencing negative surgical outcomes in adult pectus excavatum patients undergoing Nuss procedure.

Authors:  Zhen Gao; Shujie Huang; Yong Tang; Sichao Wang; Weitao Zhuang; Yu Ding; Hansheng Wu; Jiming Tang; Dongkun Zhang; Haiyu Zhou; Xiaosong Ben; Liang Xie; Gang Chen; Guibin Qiao
Journal:  Ann Transl Med       Date:  2021-08

4.  The Safety and Efficacy of the Modified Single Incision Non-thoracoscopic Nuss Procedure for Children With Pectus Excavatum.

Authors:  Jishuo Song; Quan Wang; Zhengxia Pan; Chun Wu; Yonggang Li; Gang Wang; Jiangtao Dai; Linyun Xi; Hongbo Li
Journal:  Front Pediatr       Date:  2022-02-08       Impact factor: 3.418

5.  A Modfied Nuss Procedure for Recurrent Pectus Excavatum of Adults.

Authors:  Lei Wang; Rui Bi; Xiao Xie; Haibo Xiao; Fengqing Hu; Lianyong Jiang
Journal:  Front Surg       Date:  2022-01-26

6.  Evolution of technique and results after permanent open repair for pectus deformities.

Authors:  Zachary W Sollie; Frank Gleason; James M Donahue; Benjamin Wei
Journal:  JTCVS Tech       Date:  2022-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.